🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was granted for transformative discoveries that clarify how the immune system targets dangerous infections while sparing the healthy tissues.

A trio of renowned researchers—Japan's Prof. Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—share this accolade.

The research identified specialized "sentinels" within the defense system that eliminate malfunctioning immune cells capable of harming the organism.

These discoveries are now paving the way for new therapies for immune disorders and malignancies.

The laureates will share a prize fund valued at 11m Swedish kronor.

Decisive Findings

"The work has been essential for understanding how the immune system functions and the reason we don't all develop serious autoimmune diseases," stated the head of the award panel.

This team's research address a core question: In what way does the defense system defend us from countless infections while leaving our healthy cells intact?

The immune system employs white blood cells that search for indicators of infection, even pathogens and bacteria it has never encountered.

These cells utilize sensors—known as recognition units—that are generated by chance in countless variations.

This gives the immune system the ability to combat a broad range of threats, but the randomness of the mechanism inevitably produces white blood cells that may target the body.

Security Guards of the Body

Scientists earlier understood that a portion of these problematic white blood cells were destroyed in the immune organ—where white blood cells develop.

This year's Nobel Prize honors the identification of regulatory T-cells—described as the immune system's "security guards"—which travel through the body to disarm other immune cells that assault the body's own tissues.

It is known that this mechanism malfunctions in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A Nobel panel stated, "The findings have established a novel area of research and accelerated the creation of innovative treatments, for instance for tumors and autoimmune diseases."

Regarding malignancies, T-regs block the body from fighting the growth, so studies are focused on lowering their quantity.

For self-attack disorders, experiments are exploring increasing T-reg cells so the body is not being harmed. A comparable approach could also be useful in reducing the chances of organ transplant failure.

Pioneering Experiments

Professor Shimon Sakaguchi, from a Japanese institution, conducted experiments on rodents that had their immune gland removed, leading to autoimmune disease.

The researcher demonstrated that injecting immune cells from other animals could prevent the illness—implying there was a system for preventing immune cells from attacking the body.

Mary Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, now at a biotech firm in San Francisco, were investigating an inherited immune disorder in mice and humans that resulted in the discovery of a genetic factor vital for how regulatory T-cells function.

"The groundbreaking research has uncovered how the body's defenses is controlled by T-reg cells, preventing it from mistakenly attacking the healthy cells," commented a prominent biological science expert.

"This research is a striking illustration of how basic physiological research can have broad consequences for human health."